Martinus Capelle
Drug Product Development & Delivery, Distinguished Scientist Johnson & Johnson
Seminars
Wednesday 2nd December 2026
Insights Exchange – What Biological Features Are Still Missing From Today’s Tumour Models?
5:00 pm
- Which aspects of the tumour microenvironment remain most difficult to capture?
- How can advanced models be made more scalable and reproducible?
- What innovations will have the biggest impact on model relevance over the next five years?
- Audience Q&As
Wednesday 2nd December 2026
Evidence – Engineering More Clinically Relevant Tumour Models to Evaluate Intratumoral Delivery & Turn Cold Tumours Hot
4:40 pm
- Exploring how tumour models can better replicate the practical realities of intratumoral dosing, distribution, and therapeutic exposure within solid tumours
- Evaluating strategies to optimise local delivery, injection approaches, and formulation design to maintain drug stability and activity within the tumour microenvironment
- Sharing future plans from the SPARC consortium on developing scalable approaches, including tumour on chips, to convert immunologically cold tumours into hot tumours that are responsive to antibody and immune-based therapies
